Cargando…
Does Therapy With Anti–TNF-α Improve Glucose Tolerance and Control in Patients With Type 2 Diabetes?
Autores principales: | Gupta-Ganguli, Malini, Cox, Kyle, Means, Blake, Gerling, Ivan, Solomon, Solomon S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3120166/ https://www.ncbi.nlm.nih.gov/pubmed/21709287 http://dx.doi.org/10.2337/dc10-1334 |
Ejemplares similares
-
Number of Circulating CD14-Positive Cells and the Serum Levels of TNF-α Are Raised in Acute Charcot Foot
por: Mabilleau, Guillaume, et al.
Publicado: (2011) -
Visceral Fat Accumulation Is Associated With Circadian Blood Pressure in Japanese Patients With Impaired Glucose Tolerance
por: Masaki, Takayuki, et al.
Publicado: (2011) -
Type 2 Diabetes and Impaired Glucose Tolerance in Two Young Adults Infected With HIV Early in Life
por: Dimock, David, et al.
Publicado: (2011) -
Response to Comment on: Leeds et al. High Prevalence of Microvascular Complications in Adults With Type 1 Diabetes and Newly Diagnosed Celiac Disease. Diabetes Care 2011;34:2158–2163
por: Leeds, John S., et al.
Publicado: (2012) -
Comment on: Boronat et al. Differences in Cardiovascular Risk Profile of Diabetic Subjects Discordantly Classified by Diagnostic Criteria Based on Glycated Hemoglobin and Oral Glucose Tolerance Test. Diabetes Care 2010;33:2671–2673
por: Kramer, Caroline K., et al.
Publicado: (2011)